Medindia LOGIN REGISTER
Medindia

Restricted Fetal Growth Due to High Maternal Blood Pressure and High Hematocrit Levels

by Savitha C Muppala on Feb 10 2010 4:39 PM

Factors such as maternal high blood pressure and high hematocrit levels (the proportion of blood that consists of red blood cells) are associated with a greater likelihood of restricted fetal growth during the first trimester, with restricted growth linked to an increased risk of preterm birth and low birth weight, according to a study in the February 10 issue of JAMA.

"Human growth and development rates are highest during the first trimester of pregnancy, when essential fetal organ development is completed. Adverse first-trimester fetal exposures might have permanent consequences for fetal and postnatal health," the authors write. "The influences of maternal physical characteristics and lifestyle habits on first-trimester fetal adaptations and the postnatal consequences are not known."

Dennis O. Mook-Kanamori, M.D., M.Sc., of Erasmus Medical Center, Rotterdam, the Netherlands, and colleagues examined the association of several maternal physical characteristics and lifestyle habits in 1,631 mothers with first-trimester fetal growth and the associations of first-trimester fetal growth restriction with the risks of adverse birth outcomes and accelerated postnatal growth until the age of 2 years. Mothers were enrolled in the study between 2001 and 2005. First-trimester fetal growth was measured as fetal crown to rump length by ultrasound between the gestational age of 10 weeks 0 days and 13 weeks 6 days.

The researchers found that maternal age was positively associated with first-trimester fetal crown to rump length and that higher diastolic blood pressure and higher hematocrit levels were associated with shorter crown to rump length. Compared with mothers who were nonsmokers and optimal users of folic acid supplements, those who both smoked and did not use folic acid supplements had shorter fetal crown to rump lengths.

"Compared with normal first-trimester fetal growth, first-trimester growth restriction was associated with increased risks of preterm birth (4.0 percent vs. 7.2 percent), low birth weight (3.5 percent vs. 7.5 percent), and small size for gestational age at birth (4.0 percent vs. 10.6 percent)," the researchers write. They also found that shorter first-trimester crown to rump length was associated with accelerated growth rates in early childhood.

"Further studies are needed to assess the associations of first-trimester growth variation on the risks of disease in later childhood and adulthood," the authors conclude.

(JAMA. 2010;303[6]:527-534. Available pre-embargo to the media at www.jamamedia.org)

Advertisement
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: First-Trimester Determination of Complications of Late Pregnancy

Advertisement
Gordon C. S. Smith, M.D., Ph.D., of the University of Cambridge, United Kingdom, writes in an accompanying editorial that this study and others indicate that fetal and infant growth are significantly related to growth and placental function in the first trimester of pregnancy.

"Hence, complications of late pregnancy may, at least for some women, already be determined in the first 3 months postconception, even before a woman has sought prenatal care. The multiple associations described suggest that combined ultrasonic and biochemical screening in early pregnancy may be able to identify women at high risk of complications in late pregnancy. The challenges for future research are to produce robust screening tests with acceptable levels of detection and prediction, and to identify interventions that are effective in improving outcome when a pregnancy has been identified as high risk."

(JAMA. 2010;303[6]:561-562. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.



Source-Eurekalert
SAV


Advertisement